Aspiriant, LLC Schwab Fundamental Emerging Mk Transaction History

Aspiriant, LLC

$3.11 Billion
Q2 2025

A detailed history of Aspiriant, LLC transactions in Schwab Fundamental Emerging Mk stock. As of the latest transaction made, Aspiriant, LLC holds 636,111 shares of FNDE stock, worth $21.7 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

636,111

Previous 654,821 2.86%

Holding current value

$21.7 Million

Previous $20.2 Million 4.12%

% of portfolio

0.68%

Previous 0.7%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$26.66 - $33.09 $498,808 - $619,113	-18,710 Reduced 2.86%	636,111 $21 Million
Q1 2025 Apr 21, 2025	SELL	$28.11 - $32.0 $310,446 - $353,408	-11,044 Reduced 1.66%	654,821 $20.2 Million
Q4 2024 Jan 16, 2025	SELL	$28.89 - $33.95 $1.24 Million - $1.46 Million	-42,951 Reduced 6.06%	665,865 $19.3 Million
Q3 2024 Oct 17, 2024	SELL	$28.02 - $32.68 $492,199 - $574,056	-17,566 Reduced 2.42%	708,816 $22.9 Million
Q2 2024 Jul 15, 2024	SELL	$27.2 - $30.7 $591,654 - $667,786	-21,752 Reduced 2.91%	726,382 $21.5 Million
Q1 2024 Apr 15, 2024	SELL	$25.58 - $27.83 $4.36 Million - $4.75 Million	-170,552 Reduced 18.56%	748,134 $20.8 Million
Q4 2023 Jan 26, 2024	SELL	$25.33 - $27.18 $3.69 Million - $3.96 Million	-145,805 Reduced 13.7%	918,686 $24.9 Million
Q3 2023 Oct 17, 2023	BUY	$26.05 - $28.35 $809,347 - $880,806	31,069 Added 3.01%	1,064,491 $27.9 Million
Q2 2023 Jul 19, 2023	SELL	$25.72 - $27.75 $114,582 - $123,626	-4,455 Reduced 0.43%	1,033,422 $27.7 Million
Q1 2023 Apr 27, 2023	SELL	$24.92 - $27.41 $3.54 Million - $3.9 Million	-142,163 Reduced 12.05%	1,037,877 $27 Million
Q4 2022 Jan 23, 2023	BUY	$23.19 - $26.37 $462,640 - $526,081	19,950 Added 1.72%	1,180,040 $0
Q3 2022 Oct 28, 2022	BUY	$23.43 - $26.69 $19.8 Million - $22.6 Million	846,196 Added 269.58%	1,160,090 $27.2 Million
Q2 2022 Jul 25, 2022	BUY	$25.56 - $29.71 $6.2 Million - $7.21 Million	242,537 Added 339.89%	313,894 $8.14 Million
Q1 2022 May 06, 2022	BUY	$26.69 - $33.2 $21,298 - $26,493	798 Added 1.13%	71,357 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$30.22 - $33.49 $408,967 - $453,220	13,533 Added 23.73%	70,559 $2.19 Million
Q3 2021 Oct 27, 2021	BUY	$30.86 - $32.92 $224,413 - $239,394	7,272 Added 14.62%	57,026 $1.84 Million
Q2 2021 Aug 13, 2021	BUY	$30.51 - $33.34 $404,074 - $441,554	13,244 Added 36.27%	49,754 $1.6 Million
Q1 2021 May 11, 2021	SELL	$28.31 - $31.2 $1 Million - $1.1 Million	-35,355 Reduced 49.2%	36,510 $1.12 Million
Q4 2020 Feb 01, 2021	BUY	$23.48 - $28.35 $522,970 - $631,439	22,273 Added 44.91%	71,865 $2.03 Million
Q3 2020 Oct 29, 2020	BUY	$23.37 - $25.29 $596,682 - $645,704	25,532 Added 106.12%	49,592 $1.18 Million
Q2 2020 Aug 06, 2020	BUY	$19.93 - $24.85 $39,202 - $48,879	1,967 Added 8.9%	24,060 $563,000
Q1 2020 May 05, 2020	BUY	$18.64 - $30.37 $411,813 - $670,964	22,093 New	22,093 $454,000
Q4 2018 Feb 04, 2019	SELL	N/A	-7,173 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	N/A	7,173 New	7,173 $205,000
Q2 2018 Aug 07, 2018	SELL	N/A	-7,173 Closed	0 $0
Q1 2018 May 04, 2018	BUY	N/A	7,173 New	7,173 $224,000

Others Institutions Holding FNDE

# of Institutions

414

Shares Held

164M

Call Options Held

Put Options Held

View Full List

About SCHWAB FUNDAMENTAL EMERGING MK

Ticker FNDE
Sector ETFs
Industry ETFs

More about FNDE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account